P

Inventor

DU GUANGYAN

US13 patents
⚠️ This page may combine multiple inventors who share the name “DU GUANGYAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DANA FARBER CANCER INST INC

8 patents
US11530219B2Dec 20, 2022

Ligands to cereblon (CRBN)

DANA FARBER CANCER INST INC3 citations71
US12110292B2Oct 8, 2024

Ligands to cereblon (CRBN)

DANA FARBER CANCER INST INC0 citations60
US12491251B2Dec 9, 2025

Degraders of cyclin-dependent kinase 7 (CDK7) and uses thereof

DANA FARBER CANCER INST INC0 citations50
US12234220B2Feb 25, 2025

Immunomodulatory compounds

DANA FARBER CANCER INST INC0 citations49
US12060366B2Aug 13, 2024

Bispecific degraders

DANA FARBER CANCER INST INC0 citations49
US12030892B2Jul 9, 2024

CRBN modulators

DANA FARBER CANCER INST INC0 citations49
US12365677B2Jul 22, 2025

Degraders that target proteins via KEAP1

DANA FARBER CANCER INST INC0 citations45
US12365664B2Jul 22, 2025

Small molecule inhibitors of SRC tyrosine kinase

DANA FARBER CANCER INST INC0 citations41

UNIV SOUTHWEST PETROLEUM

2 patents
US10364388B2Jul 30, 2019

Phase change fracturing fluid system for phase change fracturing

UNIV SOUTHWEST PETROLEUM0 citations46
US10301919B2May 28, 2019

Phase-change hydraulic fracturing process

UNIV SOUTHWEST PETROLEUM0 citations35

UNIV CORNELL

2 patents
US10711036B2Jul 14, 2020

MALT1 inhibitors and uses thereof

UNIV CORNELL0 citations38
US10689366B2Jun 23, 2020

Compounds for MALT1 degredation

UNIV CORNELL0 citations37

BLUEPRINT MEDICINES CORP

1 patent
US12448379B2Oct 21, 2025

Wild type kit inhibitors

BLUEPRINT MEDICINES CORP0 citations48